Riskpilot← Back to searchSign inGet full accessIntertek ScanBi Diagnostics AB
ABActiveOrg 5566234893Elevenborgsvägen 2Research and experimental development on natural sciences and engineering · NACE 7210Est. 200220-49 employees
Revenue 2024
SEK 33,4M
-2% vs 2023
EBITDA margin
8.3%
+679% vs 2023
Equity ratio
32.8%
Financial strength
Net profit 2024
SEK 152K
+196% vs 2023
| Revenue | SEK 33,4M | -2% |
| EBITDA | SEK 2,8M | +679% |
| Net profit | SEK 152K | +196% |
| Total assets | SEK 28,6M | -1% |
| Equity | SEK 9,4M | +2% |
| Employees | — | — |
Legal name
Intertek ScanBi Diagnostics AB
Org number
5566234893
Legal form
Aktiebolag
NACE code
7210 · Research and experimental development on natural sciences and engineering
Founded
8 februari 2002
Share capital
SEK 100 000
Employees
20-49
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Dessutom har verkställande direktören rätt att teckna firman beträffande löpande förvaltningsåtgärder
Company purpose
Bolaget skall bedriva spårbarhet av genetiskt modifierade organismer (GMO), genspårning för olika agrara och veterinärmedicinska applikationer, nationell och internationell forskning, utveckling, design, handel, rådgivning och nätverk inom agro, miljö, bioteknologi och finans, äga och förvalta fastigheter, bedriva handel med värdepapper och därmed förenlig verksamhet.
Address
Elevenborgsvägen 2
Email
agritech.sweden@intertek.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | 17 262 | 20 229 | 19 347 | 15 927 | 23 228 | 28 438 | 33 931 | 33 372 |
| Staff expenses | — | — | — | — | — | — | — | — | — | −17 947 |
| EBITDA | 1 204 | 1 311 | 1 627 | 4 125 | 196 | −688 | 2 158 | 1 479 | 357 | 2 782 |
| Depreciation & amort. | −450 | −483 | −285 | −288 | −466 | −478 | −442 | −424 | −1 382 | −1 973 |
| EBIT | 754 | 828 | 1 342 | 3 837 | −270 | −1 166 | 1 716 | 1 055 | −1 025 | 809 |
| Net financials | — | 21 | −1 | −3 | −3 | −3 | −2 | −1 | −28 | −205 |
| Profit before tax | 865 | 849 | 1 276 | 3 580 | 5 | −1 090 | 1 714 | 1 053 | −158 | 604 |
| Tax | −191 | −188 | −281 | −789 | −2 | −0 | −130 | −236 | −0 | −451 |
| Net profit | 674 | 661 | 995 | 2 791 | 3 | −1 090 | 1 584 | 817 | −158 | 152 |
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 6 917 | 7 796 | 9 426 | 14 939 | 12 433 | 12 452 | 17 155 | 16 550 | 28 875 | 28 605 |
| Equity | 3 634 | 4 294 | 5 289 | 8 079 | 8 082 | 6 992 | 8 577 | 9 394 | 9 236 | 9 388 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | — |
| Short-term debt | 3 244 | 3 463 | 4 033 | 6 502 | 4 271 | 5 460 | 8 579 | 7 156 | 19 639 | 19 217 |
| Total debt | 3 244 | 3 463 | 4 033 | 6 502 | 4 271 | 5 460 | 8 579 | 7 156 | 19 639 | 19 217 |
EBITDA margin
8.3%
This company
15.8%
Market median
-47% vs market
20152024
Equity ratio
32.8%
This company
38.2%
Market median
+14% vs market
20152024
Return on equity
1.6%
This company
18.4%
Market median
-91% vs market
20152024
Net profit margin
0.5%
This company
8.1%
Market median
-94% vs market
20152024
Asset turnover
1.17×
This company
1.12×
Market median
+4% vs market
20152024
Debt / equity
2.05×
This company
0.62×
Market median
-231% vs market
20152024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Bolagsverket / SCB · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Bolagsverket / SCB · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Bolagsverket / SCB · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via Bolagsverket / SCB · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via Bolagsverket / SCB · Period 2015-01-01 – 2015-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
GE Chief Executive Officer | Chief Executive Officer | 2025 | — | — |
RI Chief Executive Officer | Chief Executive Officer | 2021 | — | — |
JR Chief Auditor | Chief Auditor | 2021 | — | — |
CO Chief Auditor | Chief Auditor | 2025 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2021 | — | — | |
| Chairman | 2022 | — | — | |
| Chairman | 2021 | — | — | |
| Board of Directors | 2022 | — | — | |
| Board of Directors | 2021 | — | — | |
| Board of Directors | 2021 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Testing Holdings Sweden Aktiebolag | Company | 100.0% | 100.0% | 0001 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
INTERTEK GROUP PLC
Intertek ScanBi Diagnostics AB Board members of Intertek ScanBi Diagnostics AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Gunilla Emilie Mellgren | Chief Executive Officer | 0 companies |
| Rune Ingemar Kristofer Vamling | Chief Executive Officer | 0 companies |
| John Robert Nyholm | Chief Auditor | 0 companies |
| Claes Olof Thore Sjödin | Chief Auditor | 0 companies |
| Ingrid Viktoria Hei Young Alstermark | Board of Directors | 0 companies |
| Erik Åke Stefan Eriksson | Chairman | 0 companies |
| Lars Johan Göran Robertson | Chairman | 0 companies |
| Rui Voss Forman De Lima Da Cunha Esteves | Board of Directors | 0 companies |
| Daniel Mathias Lindgren | Board of Directors | 0 companies |
| Josefin Amanda Sterky | Board of Directors | 0 companies |